低级别浆液性输卵管癌的临床试验
总计838个结果
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Eli Lilly and Company; Genentech, Inc.; Brigham and Women's Hospital 和其他合作者终止
-
Royal College of Obstetricians and Gynecologists完全的
-
AstraZenecaRUSSCO (Russian Society of Clinical Oncology)完全的
-
National Cancer Institute (NCI)完全的复发性输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | IV 期输卵管癌 | IV 期卵巢癌 | IV 期原发性腹膜癌美国, 加拿大
-
Hoffmann-La RocheGOG Foundation; European Network of Gynaecological Oncological Trial Groups (ENGOT)完全的腹膜肿瘤 | 卵巢癌 | 输卵管癌大韩民国, 美国, 意大利, 比利时, 澳大利亚, 法国, 奥地利, 中国, 丹麦, 德国, 希腊, 西班牙, 瑞典, 日本, 俄罗斯联邦, 火鸡, 挪威, 巴西, 捷克语, 芬兰, 波兰, 以色列
-
zr Pharma & GmbHBristol-Myers Squibb; Foundation Medicine终止
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)招聘中
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)Incyte Corporation主动,不招人
-
University Health Network, TorontoMerck Sharp & Dohme LLC; ImmunoVaccine Technologies, Inc. (IMV Inc.)主动,不招人
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)主动,不招人输卵管癌 | 卵巢癌 | 输卵管子宫内膜样腺癌 | 输卵管浆液性腺癌 | 原发性腹膜浆液性腺癌 | 原发性腹膜癌 | 卵巢高级别浆液性腺癌 | 原发性腹膜子宫内膜样腺癌 | 卵巢高级别子宫内膜样腺癌美国
-
Emory UniversityGenentech, Inc.撤销
-
Guangxi Medical University尚未招聘
-
Ludwig Institute for Cancer ResearchRoswell Park Cancer Institute完全的
-
Ludwig Institute for Cancer ResearchNational Cancer Institute (NCI)完全的
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)终止
-
AstraZeneca完全的
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)撤销卵巢浆液性囊腺癌 | 复发性卵巢上皮癌 | 复发性原发性腹膜腔癌 | 复发性卵巢生殖细胞肿瘤 | 卵巢乳头状浆液性癌 | 复发性输卵管癌美国
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH)完全的
-
Charite University, Berlin, GermanyKliniken Essen-Mitte招聘中
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH)完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's Hospital完全的
-
University Health Network, TorontoNational Cancer Institute (NCI)完全的
-
Medical University Innsbruck未知
-
Korean Gynecologic Oncology Group未知
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人进行性疾病 | 复发性输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | 复发性子宫内膜癌 | 子宫内膜腺癌 | 原发性腹膜高级别浆液性腺癌 | 铂类耐药卵巢癌 | 高级别卵巢浆液性腺癌 | 有害的 BRCA1 基因突变 | 有害的 BRCA2 基因突变美国
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)终止
-
Avenge Bio, Inc终止输卵管癌 | 原发性腹膜腔癌 | 原发性腹膜癌 | 肿瘤,卵巢 | 腺癌 卵巢 | 卵巢浆液性腺癌 | 原发性腹膜浆液性腺癌 | 高级别浆液性腺癌美国
-
National Cancer Institute (NCI)终止
-
Daiichi SankyoMerck Sharp & Dohme LLC招聘中
-
M.D. Anderson Cancer Center招聘中
-
SCRI Development Innovations, LLCGlaxoSmithKline终止
-
Roswell Park Cancer InstituteEisai Inc.完全的
-
British Columbia Cancer AgencyOzmosis Research Inc.未知
-
National Cancer Institute (NCI)完全的
-
Mayo ClinicNational Cancer Institute (NCI)完全的
-
Ludwig Institute for Cancer ResearchRoswell Park Cancer Institute; New York University Cancer Institute完全的
-
University of Texas Southwestern Medical CenterAstraZeneca终止
-
Massachusetts General HospitalNational Cancer Institute (NCI); Genentech, Inc.未知